Effects of Vitamin D, Omega-3 Fatty Acids and a Home Exercise Program on Prevention of Pre-Frailty in Older Adults: The DO-HEALTH Randomized Clinical Trial

被引:18
|
作者
Gagesch, Michael [1 ,2 ,3 ]
Wieczorek, M. [1 ,2 ,3 ]
Vellas, B. [4 ]
Kressig, R. W. [5 ]
Rizzoli, R. [6 ,7 ]
Kanis, J. [8 ,9 ]
Willett, W. C. [10 ,11 ]
Egli, A. [2 ,3 ]
Lang, W. [2 ,3 ]
Orav, E. J. [12 ]
Bischoff-Ferrari, H. A. [1 ,2 ,3 ,13 ]
机构
[1] Univ Hosp Zurich, Dept Aging Med, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Univ Hosp Zurich, Ctr Aging & Mobil, Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Univ Toulouse, Toulouse Univ Hosp, Gerontopole, INSERM,UMR 1295, Toulouse, France
[5] Univ Dept Geriatr Med FELIX PLATTER, Basel, Switzerland
[6] Geneva Univ Hosp, Serv Bone Dis, Geneva, Switzerland
[7] Fac Med, Geneva, Switzerland
[8] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia
[9] Univ Sheffield, Med Sch, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
[10] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[11] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[12] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[13] Univ Clin Aging Med, City Hosp Zurich, Zurich, Switzerland
来源
JOURNAL OF FRAILTY & AGING | 2023年 / 12卷 / 01期
关键词
Frailty prevention; clinical trial; older adults; POLYUNSATURATED FATTY-ACIDS; D SUPPLEMENTATION; ASSOCIATION; MORTALITY; MANAGEMENT; STRENGTH; WOMEN;
D O I
10.14283/jfa.2022.48
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BACKGROUND: The benefits of supplemental vitamin D3, marine omega-3 fatty acids, and a simple home exercise program (SHEP) on frailty prevention in generally healthy community-dwelling older adults are unclear. OBJECTIVE: To test the effect of vitamin D3, omega-3s, and a SHEP, alone or in combination on incident pre-frailty and frailty in robust older adults over a follow-up of 36 months. METHODS: DO-HEALTH is a multi-center, double-blind, placebo-controlled, 2x2x2 factorial randomized clinical trial among generally healthy European adults aged 70 years or older, who had no major health events in the 5 years prior to enrollment, sufficient mobility and intact cognitive function. As a secondary outcome of the DO-HEALTH trial, among the subset of participants who were robust at baseline, we tested the individual and combined benefits of supplemental 2,000 IU/day of vitamin D3, 1 g/day of marine omega-3s, and a SHEP on the odds of being pre-frail and frail over 3 years of follow-up. RESULTS: At baseline, 1,137 out of 2,157 participants were robust (mean age 74.3 years, 56.5% women, mean gait speed 1.18 m/s). Over a median follow-up time of 2.9 years, 696 (61.2%) became pre-frail and 29 (2.6%) frail. Odds ratios for becoming pre-frail were not significantly lower for vitamin D3, or omega 3-s, or SHEP, individually, compared to control (placebo for the supplements and control exercise). However, the three treatments combined showed significantly decreased odds (OR 0.61 [95% CI 0.38-0.98; p=0.04) of becoming pre-frail compared to control. None of the individual treatments or their combination significantly reduced the odds of becoming frail. CONCLUSION: Robust, generally healthy and active older adults without major comorbidities, may benefit from a combination of high-dose, supplemental vitamin D3, marine omega-3s, and SHEP with regard to the risk of becoming pre-frail over 3 years.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [41] Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
    Dong, Yanbin
    Zhu, Haidong
    Chen, Li
    Huang, Ying
    Christen, William
    Cook, Nancy R.
    Copeland, Trisha
    Mora, Samia
    Buring, Julie E.
    Lee, I-Min
    Costenbader, Karen H.
    Manson, JoAnn E.
    NUTRIENTS, 2022, 14 (24)
  • [42] One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
    Demler, Olga V.
    Liu, Yanyan
    Luttmann-Gibson, Heike
    Watrous, Jeramie D.
    Lagerborg, Kim A.
    Dashti, Hesam
    Giulianini, Franco
    Heath, Mallory
    Camargo, Carlos A., Jr.
    Harris, William S.
    Wohlgemuth, Jay G.
    Andres, Allen M.
    Tivari, Saumya
    Long, Tao
    Najhawan, Mahan
    Dao, Khoi
    Prentice, James G.
    Larsen, Julia A.
    Okereke, Olivia I.
    Costenbader, Karen H.
    Buring, Julie E.
    Manson, JoAnn E.
    Cheng, Susan
    Jain, Mohit
    Mora, Samia
    METABOLITES, 2020, 10 (11) : 1 - 20
  • [43] The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults
    Danthiir, Vanessa
    Burns, Nicholas R.
    Nettelbeck, Ted
    Wilson, Carlene
    Wittert, Gary
    NUTRITION JOURNAL, 2011, 10
  • [44] Effects of an Omega-3 and Vitamin D Supplement on Fatty Acids and Vitamin D Serum Levels in Double-Blinded, Randomized, Controlled Trials in Healthy and Crohn's Disease Populations
    Laing, Bobbi Brennan
    Cavadino, Alana
    Ellett, Stephanie
    Ferguson, Lynnette R.
    NUTRIENTS, 2020, 12 (04)
  • [45] The Effect of Omega-3 Fatty Acids on Thromboxane, Brain-Derived Neurotrophic Factor, Homocysteine, and Vitamin D in Depressive Children and Adolescents: Randomized Controlled Trial
    Paduchova, Zuzana
    Katrencikova, Barbora
    Vavakova, Magdalena
    Laubertova, Lucia
    Nagyova, Zuzana
    Garaiova, Iveta
    Durackova, Zdenka
    Trebaticka, Jana
    NUTRIENTS, 2021, 13 (04)
  • [46] The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults
    Vanessa Danthiir
    Nicholas R Burns
    Ted Nettelbeck
    Carlene Wilson
    Gary Wittert
    Nutrition Journal, 10
  • [47] Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of a Double-Blind Randomized Clinical Trial (FORWARD) (NCT00597220)
    Macchia, Alejandro
    Grancelli, Hugo
    Varini, Sergio
    Nul, Daniel
    Ferrante, Daniel
    Mariani, Javier
    Laffaye, Nicolas
    Badra, Raul
    Figal, Julio
    Ramos, Silvina
    Tognoni, Gianni
    Doval, Hernan
    CIRCULATION, 2012, 126 (23) : 2780 - 2781
  • [48] A Randomized Controlled Clinical Trial Investigating the Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Biomarkers of Oxidative Stress, Inflammation and Pregnancy Outcomes in Gestational Diabetes
    Jamilian, Mehri
    Dizaji, Shahrzad Hashemi
    Bahmani, Fereshteh
    Taghizadeh, Mohsen
    Memarzadeh, Mohammad Reza
    Karamali, Maryam
    Akbari, Maryam
    Asemi, Zatollah
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (02) : 143 - 149
  • [49] Effects of a diet containing different sources of omega-3 fatty acids on kidney-related biomarkers in overweight and obese individuals: a randomized clinical trial
    Fatahi, Somaye
    Haghighatdoost, Fahime
    Larijani, Bagher
    Surkan, Pamela J.
    Azadbakht, Leila
    NUTRITION & FOOD SCIENCE, 2021, 51 (05): : 866 - 877
  • [50] Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults
    Flock, Michael R.
    Skulas-Ray, Ann C.
    Harris, William S.
    Gaugler, Trent L.
    Fleming, Jennifer A.
    Kris-Etherton, Penny M.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2014, 91 (04): : 161 - 168